RNU6-894P

Across TCGA pan-cancer cohorts, RNU6-894P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-894P data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RNU6-894P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-894P expression acts as an unfavorable survival marker.

LUSC, LIHC, and OV are the cancer types where RNU6-894P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	All	0.229	0.665	<.001	75	view →
LIHC	OS	Tertile	All	0.092	0.783	<.001	72	view →
OV	DFS	Tertile	II,III,IV	0.303	0.543	.030	54	view →
UCEC	DFS	Tertile	All	0.784	0.898	.003	30	view →
DLBC	OS	Tertile	All	0.054	0.842	<.001	18	view →
SKCM	OS	Tertile	III,IV	0.216	0.721	.001	9	view →
HNSC	DFS	Tertile	II,III,IV	0.208	0.685	.043	9	view →
SARC	OS	Tertile	All	0.241	0.766	.022	9	view →
STAD	OS	Tertile	III,IV	0.162	0.502	.049	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU6-894P–LUSC (DFS)

Open the LUSC breakdown →